SRPT Alert: Kehoe Law Firm, P.C. Investigating Potential Securities Fraud Claims on Behalf of Investors of Sarepta Therapeutics, Inc

Philadelphia, Pennsylvania--(Newsfile Corp. - June 17, 2025) - Kehoe Law Firm, P.C. is investigating potential violations of federal securities laws and claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta") (NASDAQ: SRPT).

On June 16, 2025, shares of Sarepta stock dropped significantly after the company "provided a safety update regarding ELEVIDYS" and reported a second "case of acute liver failure (ALF) resulting in death."

By the close of trading on June 16, 2025, Sarepta shares had dropped more than 42%.

Additional information can be obtained at https://kehoelawfirm.com/sarepta-therapeutics-srpt/.

ABOUT KEHOE LAW FIRM, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

This press release may constitute attorney advertising.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/255815